In addition, the company offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments ...

Glioblastoma, the most aggressive and deadly type of brain cancer, is known to have a very poor prognosis — but a new study suggests that a pain-relieving drug could extend survival. Researchers ...

Sarah Richards never imagined she’d end up struggling with pain medication. After a car accident left her with chronic back pain, prescription opioids seemed like a lifeline. Three months later ...

For the last quarter century, one of the world’s most capable drug developers toiled to make a new, non-addictive kind of painkiller. The journey was fittingly excruciating. Pain, as Vertex ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty big deal,” Gupta said. “As you just mentioned, it’s been ...

A new type of pain medication to hit the market will create an alternative —it’s not an opioid — and could open the door to more drugs of this type in the future. CNN values your feedback 1.

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr. Jianguo Cheng, from the Cleveland Clinic, constantly works with patients ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults. Experts say the drug, which is billed as nonaddictive, could reduce the number ...